VEGF(165) requires extracellular matrix components to induce mitogenic effects and migratory response in breast cancer cells (Q43747243)

26 November 2017

title

VEGF(165) requires extracellular matrix components to induce mitogenic effects and migratory response in breast cancer cells (English)

1 reference

26 November 2017

0 references

Miralem T

1

1 reference

26 November 2017

Steinberg R

series ordinal

2

1 reference

26 November 2017

Price D

series ordinal

3

1 reference

26 November 2017

Avraham H

series ordinal

4

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

26 November 2017

1 reference

26 November 2017

volume

20

1 reference

26 November 2017

issue

39

1 reference

26 November 2017

page(s)

5511-5524

1 reference

Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phosphatidylinositol-3 kinase

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

Heregulin induces phosphorylation of BRCA1 through phosphatidylinositol 3-Kinase/AKT in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

21 January 2018

Phosphoinositide kinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

Crystal structure of the NK1 fragment of HGF/SF suggests a novel mode for growth factor dimerization and receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

PDGF- and insulin-dependent pp70S6k activation mediated by phosphatidylinositol-3-OH kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

Interaction of the Flt-1 tyrosine kinase receptor with the p85 subunit of phosphatidylinositol 3-kinase. Mapping of a novel site involved in binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

An 11-amino acid sequence from c-met initiates epithelial chemotaxis via phosphatidylinositol 3-kinase and phospholipase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

Identification of a Heparin Binding Peptide on the Extracellular Domain of the KDR VEGF Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

Biological activity and phosphorylation sites of the bacterially expressed cytosolic domain of the KDR VEGF-receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

A synthetic inhibitor of the mitogen-activated protein kinase cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

Glypican-1 is a VEGF165 binding proteoglycan that acts as an extracellular chaperone for VEGF165

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

Initial adhesion of human fibroblasts in serum-free medium: Possible role of secreted fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

Specific binding of [3H]heparin to human carcinoma SW-13 and other mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

Basic fibroblast-like growth factor is present in the conditioned medium of simian sarcoma virus transformed NRK cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

The PHSRN sequence induces extracellular matrix invasion and accelerates wound healing in obese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

Interaction between erbB-receptors and heregulin in breast cancer tumor progression and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

The regulation of tyrosine kinase signalling pathways by growth factor and G-protein-coupled receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

Heparin inhibits mitogen-activated protein kinase-dependent and -independent c-fos induction in mesangial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

Epidermal growth factor-related peptides in the pathogenesis of human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

Sequence analysis andin vivoexpression show that alternative splicing of ED-B and ED-A regions of the human fibronectin gene are independent events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

Vascular endothelial growth factor up-regulates ICAM-1 expression via the phosphatidylinositol 3 OH-kinase/AKT/Nitric oxide pathway and modulates migration of brain microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

Syndecan-4 signals cooperatively with integrins in a Rho-dependent manner in the assembly of focal adhesions and actin stress fibers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

Heparinase inhibits neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

Production of VEGF and expression of the VEGF receptors Flt-1 and KDR in primary cultures of epithelial and stromal cells derived from breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

Proteoglycans in cell regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

VEGF receptor subtypes KDR and FLT1 show different sensitivities to heparin and placenta growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

Vascular endothelial growth factor: a new member of the platelet-derived growth factor gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

The serum response element

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

Ternary complex factors: growth factor regulated transcriptional activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

A synthetic peptide from the COOH-terminal heparin-binding domain of fibronectin promotes focal adhesion formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

Lipid-Regulated Kinases: Some Common Themes at Last

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

Differential expression of vascular endothelial growth factor (vascular permeability factor) forms in rat tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

7 January 2021

Molecular modeling of protein-glycosaminoglycan interactions.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

7 January 2021

Integrins and signal transduction pathways: the road taken

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

7 January 2021

Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

7 January 2021

Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

7 January 2021

Role of PI 3-kinase in angiopoietin-1-mediated migration and attachment-dependent survival of endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

7 January 2021

Heparin protects basic and acidic FGF from inactivation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

7 January 2021

A Cell Binding Domain from the α3 Chain of Type IV Collagen Inhibits Proliferation of Melanoma Cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

7 January 2021

Specific fixation of bovine brain and retinal acidic and basic fibroblast growth factors to mouse embryonic eye basement membranes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

7 January 2021

A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

7 January 2021

Vascular endothelial growth factor and its receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

7 January 2021

Taxol and cisplatin inhibit proliferation of T47D human breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

7 January 2021

Collagen type I enhances endothelin-mediated contraction and induces nonproliferating phenotype in mesangial cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

7 January 2021

Abnormal deposition of basement membrane and connective tissue components in dimethylbenzanthracene-induced rat mammary tumours: an immunocytochemical and ultrastructural study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

7 January 2021

Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

7 January 2021

Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

7 January 2021

Inhibition of tumor cell proliferation by type IV collagen requires increased levels of cAMP

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

7 January 2021

The role of phosphatidylinositol 3-kinase in vascular endothelial growth factor signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

7 January 2021

MAP kinases, phosphatidylinositol 3-kinase, and p70 S6 kinase mediate the mitogenic response of human endothelial cells to vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204753

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1204753

1 reference

Dimensions Publication ID

26 November 2017

1022353235

0 references

1 reference